THE PROGNOSTIC IMPORTANCE OF SYNCYTIAL GROWTH-PATTERN IN MEDULLARY CARCINOMA OF THE BREAST

被引:4
作者
PEDERSEN, L
SCHIODT, T
HOLCK, S
ZEDELER, K
机构
[1] RIGSHOSP,DEPT PATHOL,DK-2100 COPENHAGEN,DENMARK
[2] FREDERIKSBORG CENT CTY HOSP,DEPT PATHOL,HILLEROD,DENMARK
[3] RIGSHOSP,FINSEN INST,DANISH BREAST CANC COOPERAT GRP,DK-2100 COPENHAGEN,DENMARK
关键词
medullary carcinoma of the breast; prognostic importance; syncytial growth pattern;
D O I
10.1111/j.1699-0463.1990.tb05016.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The histopathological criteria for medullary carcinoma of the breast (MC) used by most pathologists today were delineated by Ridolfi et al. in 1977. The prime criterion is 'A predominantly syncytial growth pattern', predominantly being defined as including 75% or more of the tumour. However, no indication has been given as to why this limit was set at 75%. The present study analyzes the prognostic importance of the extent of syncytial growth in a population of 102 breast cancers with medullary features. Generally, we find a positive prognostic influence of an extensive syncytial growth. The prognostic importance of setting the limit for predominantly syncytial growth at 90% and at 75%, respectively, is evaluated. This comparative study provides no basis for changing the definition of predominantly syncytial growth pattern.
引用
收藏
页码:921 / 926
页数:6
相关论文
共 21 条
  • [1] ANDERSEN KW, 1981, DAN MED BULL, V28, P102
  • [2] HOST RESISTANCE AND SURVIVAL IN CARCINOMA OF BREAST - A STUDY OF 104 CASES OF MEDULLARY CARCINOMA IN A SERIES OF 1,411 CASES OF BREAST CANCER FOLLOWED FOR 20 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    FIELD, JR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1970, 3 (5716): : 181 - +
  • [3] FISHER ER, 1975, CANCER, V36, P1, DOI 10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO
  • [4] 2-4
  • [5] FOOTE FW, 1946, SURGERY, V19, P74
  • [6] FORQUET A, 1987, RADIOTHER ONCOL, V10, P1
  • [7] HAAGENSEN CD, 1973, DISEASES BREAST
  • [8] HARTVEIT F, 1974, ACTA PATH MICRO IM A, VA 82, P319
  • [9] MCDIVITT RW, 1968, ATLAS TUMOR PATHOL, P57
  • [10] MOORE OS, 1949, CANCER, V2, P635, DOI 10.1002/1097-0142(194907)2:4<635::AID-CNCR2820020411>3.0.CO